Welcome
New Home-Mid Content
WELCOME
The King's Thrombosis Centre is a leading multidisciplinary clinical and research group dedicated to the diagnosis and treatment of hypercoagulable conditions.
We are a designated Haemophilia Centre and were the first National Venous Thromboembolism (VTE) Exemplar Centre, reflecting our national leadership in the prevention and treatment of VTE. Our clinical trials unit works in partnership with industry to develop new treatments for VTE prevention and treatment.
THE FIRST REGISTRY
With the next generation of oral anticoagulants entering clinical practice, the FIRST registry will provide an important data tool to increase knowledge and improve the quality of care of patients with VTE.
King's Thrombosis Centre COVID-19 Research
Clinicians and researchers in the King’s Thrombosis Centre are completing a number of research studies relating to the COVID-19 pandemic.
Click here to view the latest publications from our centre, relating to this.
Click here to view the BBC interview with Prof Roopen Arya on thrombosis in COVID-19.
VTE EXEMPLAR CENTRE NETWORK WEBSITE
After being hosted at the King's Thrombosis Centre website since its launch in 2007, the website is now managed as part of the National VTE prevention Programme at NHS England. Click here to access the site.
Latest News
-
Anticoagulation news items. Week commencing 19th October 2020
Rituximab for treating inhibitors in people with inherited severe haemophilia Cochrane Database of Systematic ReviewsThis review did not identify any relevant randomised controlled trials. The research evidence available was limited…
-
Anticoagulation news items. Week commencing 12th October 2020
Warfarin and other anticoagulants – monitoring of patients during the COVID-19 pandemic Medicines and Healthcare products Regulatory AgencyMHRA has published guidance following concerns over an apparent increase in the number…
-
Anticoagulation news items. Week commencing 5th October 2020
Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack Cochrane Database of Systematic ReviewsThis review (15 RCTs; n=17,091) concludes multiple antiplatelet drugs reduced…
